Company / Income Tax
NeoGenomics Laboratories, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$2.2M
FY2025
5-year range
-$15.1M / -$1.9M
FY2021-FY2025
Trend
-15.1%
vs FY2024
Sector context
#148 of 162
Health Care
What the data says
Among 162 Health Care companies, NeoGenomics Laboratories, Inc. is in the top 9% for income tax. Income Tax has fluctuated over the past 10 years, ranging from -$18M in FY2020 to $1M in FY2018.
Based on SEC 10-K filings.
-$2M in FY2025.
Increased from -$9M to -$2M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 162This company -$2.2M Sector average $145.4M
▼
-101.5% below sector average
Key checks
Key Insights
- In FY2025, income tax decreased 15.1% year-over-year.
- Ranks #148 out of 162 companies in the Health Care sector.
- Peak income tax was recorded in FY2018.
- Lowest income tax in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.2M | -15.1% |
| FY2024 | -$1.9M | +78.7% |
| FY2023 | -$9.1M | +39.5% |
| FY2022 | -$15.1M | -124.3% |
| FY2021 | -$6.7M | +63.1% |
| FY2020 | -$18.2M | -318.0% |
| FY2019 | -$4.4M | -468.3% |
| FY2018 | $1.2M | +152.5% |
| FY2017 | -$2.3M | -32.5% |
| FY2016 | -$1.7M | +12.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026